key: cord-0738392-476mj03g authors: Riley, Angela C.; Wisseh, Cheryl; Campbell, Hope; Nonyel, Nkem; Butler, Lakesha; Shaw, Trishia title: Socialized and Traumatized: Pharmacists, Underserved Patients, & the COVID-19 Vaccine date: 2021-06-01 journal: J Am Pharm Assoc (2003) DOI: 10.1016/j.japh.2021.05.020 sha: 77f218119cace360f3a1727df8c3776003138eae doc_id: 738392 cord_uid: 476mj03g The COVID-19 pandemic has brought attention and awareness to existing health disparities in underrepresented minority communities. Not only were minoritized populations disproportionality negatively impacted by COVID19, but history of mistrust and other systemic barriers prevented access to treatment, testing, and even impacts access and acceptance of the current vaccines. Pharmacists are essential to the provision of care for the population, particularly during global crises. Minoritized pharmacists play an even greater role, as partners with public health officials to translate science and build trust in minoritized community members who are hesitant about vaccine development, safety, and efficacy. Dedicated to representing the views and ideals of minority pharmacists on critical issues affecting health care, the National Pharmaceutical Association (NPhA) has been at the forefront of the pandemic. Throughout the pandemic, NPhA has prioritized the role of underrepresented practitioners, striving to improve awareness and access to underrepresented communities. While delivering education and information about the COVID-19 vaccine: clinical trials, population prioritization, and federal funding to our service areas and target populations, NPhA continues to challenge healthcare myths, address historical conflicts and systemic racism that often dictates the access to treatment and quality healthcare. , and on March 13, 2020, the World Health Organization (WHO) 2 declared COVID-19 a pandemic. 1 As the world struggled to implement treatment protocols and 3 preventative measures, the death count steadily increased. Today, more than 500,000 deaths have been 4 reported in the United States. 2 The COVID-19 pandemic brought attention and awareness to existing health disparities within 6 marginalized communities. Populations of color are disproportionality negatively impacted by COVID19. 7 Hospitalization rates are 2.9 times higher among Non-Hispanic Black/African-American persons and 3.1 8 times higher among Hispanic or Latino persons. 3 Among Black/African-American and Hispanic/Latino 9 populations, death rates were 1.9 times higher than Whites. 3 Moreover, Black/African practitioners are 10 still defined by the color of their skin rather than the content of their character, depth of knowledge, or 11 expertise. 4 As such, they are subject to the same consequences of structural racism and bias that their 12 minoritized patients face and can themselves harbor mistrust in healthcare systems and vaccines overall. J o u r n a l P r e -p r o o f 1 to generation genetically and behaviorally. 6 Medical mistrust is different from medical distrust. While 2 distrust implies an absence of trust or doubt and suspicion stemming from experience or specific 3 knowledge, mistrust is a lack of confidence based on feelings or instincts instead of informed expertise or 4 opinion. 7 Medical mistrust within the Black/African-American community originates from interpersonal 5 and institutionalized racism, which continually reproduces anti-Black sentiment within the society. Many 6 studies cite the Tuskegee Study of Untreated Syphilis in the Negro Male (TSUS) as the primary source of 7 Black/African-Americans' mistrust of the U.S. health care system. 8, 9, 10 However, there were several 8 unethical, inhumane, and abusive practices rooted in White supremacy that led to the design, 9 implementation, and evaluation of TSUS. During the Jim Crow era, the contemporary belief was that the 10 health disparities surrounding high mortality rates within the Black/African-American community were 11 due to their inherent genetic inferiority and not the lack of access to quality health care services and other 12 resources that impacted health as the cause. 11 These historical injustices led to generations of 13 Black/African-Americans being socialized in an environment that perpetuates medical mistrust. 9, 10 Often, 14 this message is merely passed down generationally in oral history from parents and grandparents. The hesitancy (e.g. confidence, complacency, and convenience). 12 The lack of confidence in the vaccines 21 themselves, the systems that administer vaccines (e.g health systems and practitioners), and the motives 22 of the political leaders have all been cited as primary causes for the delayed uptake in minoritized 23 communities. 12,13 24 In response to the pandemic, the U.S. government launched a project called "Operation Warp 25 Speed" to produce vaccines, therapeutic agents, and diagnostic tests. 14 There was much enthusiasm in 26 J o u r n a l P r e -p r o o f 1 emergency use authorizations (EUA) by the Food and Drug Administration (FDA). With greater than 2 90% efficacy reported for each vaccine, the possibility of returning to pre-COVID-19 days was on the 3 mind of all Americans. 15, 16 Tempering the enthusiasm was the fear that political involvement, 4 pharmaceutical lack of transparency, and a rapid development and authorization process might have 5 compromised safety 13 . The operation's name caused concern that speed rather than safety and efficacy 6 would be the priority. Recognizing the public's concern regarding vaccine safety, chief executive officers 7 of nine pharmaceutical companies issued a joint statement to assure the people that they were committed Steps to ensure that patients from minoritized communities are best served: A Timeline of COVID-19 Developments in 2020 United States of America: WHO Coronavirus disease (COVID-19) dashboard. WHO.int CDC. COVID-19 hospitalization and death by race/ethnicity. CDC.gov. Accessed Addressing Harmful Bias and Eliminating Discrimination in Health Professions Learning Environments: An Urgent Challenge, Academic Medicine Is doctor-patient race concordance associated with greater satisfaction with care? My grandmother's hands: racialized trauma and the pathways to mending our hearts and bodies Trustworthiness: A Principle for Processes, Practices, and Partnerships to Improve Health Among Disadvantaged and Disenfranchised Psychosocial Correlates of Medical Mistrust Among African American Men Mistrust in physicians does not explain black-white disparities in primary care and emergency department utilization: the importance of socialization during the Jim Crow era The Legacy of Tuskegee and Trust in Medical Care: Is Tuskegee Responsible for Race Differences in Mistrust of Medical Care An American Health Dilemma: A History of Blacks in the Health System Vaccine hesitancy: Definition, scope and determinants Trump's Surgeon General Battles Rising Covid Vaccine Skepticism Developing a SARS-CoV-2 Vaccine at Warp Speed Coronavirus Vaccine Tracker. The New York Times Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine There are seven coronavirus vaccine candidates being tested in the U.S.-Here is where they stand National Pharmaceutical Association website Black doctors want to vet vaccine process, worried about mistrust from years of medical racism Serving as Trusted Messengers about COVID-19 Vaccines and Therapeutics Addressing Racial Equity in Vaccine Distribution Latest Data on COVID-19 Vaccinations Race/Ethnicity. KFF Lack of internet has limited vaccine access for minorities Black Americans Are Getting Vaccinated at Lower Rates Than White Americans. Kaiser Health News The Health Center COVID-19 Vaccination Program is Prioritizing Hard-to-Reach Communities Executive Summary: Pharmacists as Frontline Responders for COVID-19 Patient Care Disadvantaged Populations Time to reconsider the word minority in academic medicine